Literature DB >> 28925385

Fine-tuning type I IFN signaling: A new chapter in the IFN saga.

Hideyuki Yanai1, Tadatsugu Taniguchi1.   

Abstract

Type I interferon (IFN) signaling is critical for intracellular antimicrobial programmes, affecting both innate and adaptive immune responses. The paper recently published in Cell demonstrates a new regulatory mechanism of the type I IFN signaling pathway by histone-lysine N-methyltransferase SETD2.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28925385      PMCID: PMC5717401          DOI: 10.1038/cr.2017.118

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  12 in total

1.  A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

Authors:  L Velazquez; M Fellous; G R Stark; S Pellegrini
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

Review 2.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor.

Authors:  C Schindler; K Shuai; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

4.  Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.

Authors:  Kun Chen; Juan Liu; Shuxun Liu; Meng Xia; Xiaomin Zhang; Dan Han; Yingming Jiang; Chunmei Wang; Xuetao Cao
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

5.  Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.

Authors:  H Harada; T Fujita; M Miyamoto; Y Kimura; M Maruyama; A Furia; T Miyata; T Taniguchi
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

6.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

Authors:  Ahjoku Amadi-Obi; Cheng-Rong Yu; Xuebin Liu; Rashid M Mahdi; Grace Levy Clarke; Robert B Nussenblatt; Igal Gery; Yun Sang Lee; Charles E Egwuagu
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

7.  Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.

Authors:  D H Kaplan; V Shankaran; A S Dighe; E Stockert; M Aguet; L J Old; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 8.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

9.  Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation.

Authors:  John W Edmunds; Louis C Mahadevan; Alison L Clayton
Journal:  EMBO J       Date:  2007-12-20       Impact factor: 11.598

Review 10.  SETD2: an epigenetic modifier with tumor suppressor functionality.

Authors:  Jun Li; Gerben Duns; Helga Westers; Rolf Sijmons; Anke van den Berg; Klaas Kok
Journal:  Oncotarget       Date:  2016-08-02
View more
  1 in total

1.  PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.

Authors:  Haridha Shivram; Steven V Le; Vishwanath R Iyer
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.